CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 82 filers reported holding CYTOSORBENTS CORP in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,130,000 | +136.4% | 114,109 | +84.7% | 0.51% | +81.4% |
Q1 2020 | $478,000 | -24.1% | 61,795 | -20.8% | 0.28% | -18.8% |
Q4 2018 | $630,000 | -51.4% | 78,027 | -22.3% | 0.34% | -34.3% |
Q3 2018 | $1,296,000 | -5.1% | 100,440 | -16.2% | 0.52% | -21.3% |
Q2 2018 | $1,366,000 | – | 119,806 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |